(Alliance News) - Trading was timid in London at the market open on Wednesday, after a series of mixed corporate updates, as investors awaited the all-important interest rate decision from the US Federal Reserve, due after the European close. Read More
(Alliance News) - Stock prices in London were called slightly higher on Wednesday, as investors awaited the all-important interest rate decision to come from the US Federal Reserve. Read More
(Alliance News) - Haleon PLC on Monday announced the pricing for offers to exchange six series of outstanding unregistered notes issued by GSK Consumer Healthcare Capital US LLC and one series by GSK Consumer Healthcare Capital UK PLC due between 2024 and 2052, which Haleon announced on September 29. Read More
(Alliance News) - Stocks in London closed in the red on Friday, but clung on for week gains, as interest rate decisions from the Bank of England and the US Federal Reserve move into focus. Read More
(Alliance News) - GSK PLC on Friday said its majority owned ViiV Healthcare venture has received the European Medicines Agency's validation for its marketing authorisation application for HIV prevention, and said its MAA for respiratory syncytial virus adult vaccine has also been accepted. Read More
(Alliance News) - GSK PLC on Thursday said a US Food & Drug Administration panel has supported daprodustat for adults on dialysis but not for non-dialysis adults, and provided an update on the ContRAst phase III programme for otilimab. Read More
Sareum Holdings PLC - Cambridge, England-based drug developer for cancer and autoimmune diseases - In the year ended June 30, pretax loss widens to GBP2.6 million from GBP1.7 million a year before. No revenue is recorded in either year, but in the previous year it brought in GBP171,000 in other operating income, with none recorded for financial 2022. Says it will discuss the future of SRA737 with partner Cancer Research Technology Pioneer Fund. Earlier this month, GSK PLC subsidiary Sierra Oncology Inc said it intends to return the rights for the SRA737 cancer treatment to CPF. Read More
(Alliance News) - GSK PLC on Friday said that a new drug application for its respiratory syncytial virus vaccine candidate has been accepted for review by the Japanese Ministry of Health, Labour & Welfare. Read More
(Alliance News) - GSK PLC on Monday said the meningitis vaccine Menveo has been approved by the US Food & Drug Administration in a single-vial presentation to help prevent disease caused by meningococcal bacteria serogroups A, C, Y, and W. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday: Read More
(Alliance News) - GSK PLC on Thursday announced a vast decline in severe respiratory syncytial virus, or RSV, disease among people aged 60 years and older who were vaccinated with its RSV vaccine candidate. Read More
(Alliance News) - Sareum Holdings PLC on Wednesday after Sierra Oncology Inc, a subsidiary of GSK PLC, said it intends to return the rights for SRA737 to the CRT Pioneer Fund LP. Read More
(Alliance News) - GSK PLC on Monday said Boostrix has been approved by the US Food & Drug Administration for immunisation during the third trimester of pregnancy to help prevent pertussis in infants less than two months of age. Read More
(Alliance News) - GSK PLC on Wednesday said its drug for metastatic non-squamous non-small cell lung cancer Jemperli, or dostarlimab, is advancing to a phase 3 trial following positive results. Read More
MGC Pharmaceuticals - Perth, Australia-based medicinal cannabis company - Appoints Yifat Steuer as the company's new chief operating officer and deputy chief executive officer. Steuer has worked across a range of pharmaceutical companies, including Johnson & Johnson, GSK PLC as well as with start-ups. The company said that Brett Mitchell has moved from executive chair to non-executive chair "to be more in line with corporate structuring of UK listed companies." Read More
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday: Read More
(Alliance News) - The mood soured just before the European equities open on Thursday. Read More
(Alliance News) - Burberry Group PLC on Wednesday said it has hired Daniel Lee, the former creative director of Italian luxury brand Bottega Veneta, to be its new design chief, as Riccardo Tisci steps down. Read More